Michael H. Carrel, President, CEO, & Director at AtriCure, Inc. (ATRC), sold 74,751 shares at $56.00 ($4.2M) on 2020-12-22, disclosed to the SEC on 2020-12-23.
Open-market sale of $4.2M ATRC by President, CEO, & Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.00 | 24,751 | $1.4M | 32.5% |
| 2 | $56.00 | 25,000 | $1.4M | 33.4% |
| 3 | $57.00 | 25,000 | $1.4M | 34.0% |
| Total | $56.00 avg | 74,751 | $4.2M | 100% |
| Filing → |
| ATRC | SELL | 2021-02-04 | $1.5M | — | Filing → |
| ATRC | SELL | 2021-01-13 | $1.5M | — | Filing → |
| ATRC | SELL | 2020-12-28 | $1.4M | — | Filing → |